Home
SaaS Financing
Venture DebtVenture debt is a term loan raised alongside an equity round — priced with interest plus warrants and a final payment. Here is who actually qualifies, how to price the warrants honestly, and what a bootstrapped SaaS company can raise instead.
SaaS companies funded since 2021
deployed to founders
Venture debt is a term loan made to a venture-backed company, usually shortly after it closes an equity round. The lender is not underwriting your assets or your profitability — it is underwriting your investors. The implicit bet is that the fund that just led your round will lead or support the next one, and that this is what will repay the loan.
That is why the pricing looks unlike any other loan. You pay interest, and on top of it the lender takes warrants — the right to buy your stock at the last round’s price — plus a final payment at maturity. The headline interest rate is not the cost of venture debt. The cost is interest plus warrants plus the final payment plus whatever the covenants constrain you from doing.
Used well, it is a genuinely good instrument: it buys 6–12 months of runway between rounds without repricing the company, and for a fast-growing VC-backed company that is often cheaper than selling more equity at today’s valuation. Used badly — to paper over a round that is not coming — it adds a fixed monthly payment and a lien to a company that already has a problem.
For most bootstrapped SaaS founders reading this, the honest answer is no — and not because of your numbers. Nearly every venture-debt lender requires an institutional equity round with a named lead investor, because the investor is the collateral. You can be profitable, growing, and retaining customers better than the average VC-backed startup and still fail that test on the first question.
You have raised an institutional equity round (typically Series A or later) with a named lead investor
That investor is a recognised fund the lender already knows and expects to support the next round
You have 9–18 months of runway left — venture debt extends a runway, it does not rescue one
You can carry a fixed monthly payment through the whole term, including a bad quarter
You accept a lien on company assets, reporting covenants, and warrants on top of interest
Bootstrapped, profitable, or revenue-funded with no institutional round — most lenders stop here
Angel- or SAFE-funded only, with no priced round and no named lead
Raising for the first time — venture debt follows equity, it rarely leads it
Unwilling to issue warrants or accept covenants and a lien on the business
Below the lender’s revenue or round-size floor, which is usually far above $10K MRR
Capital underwritten on your recurring revenue rather than on your investors. Revenue based financing and recurring revenue financing price your MRR, growth, retention, and margins — no round, no lead investor, no warrants. Founderpath funds from $10K MRR, returns an offer in about 24 hours after you connect your billing and bank data, and takes no equity, no board seat, and no warrants. The trade-off is real and worth naming: this is growth capital sized to the revenue you already have, not a runway bridge sized to the round you are hoping to raise.
Six things price a venture-debt facility. Only the first one shows up in the headline.
Usually floating — a base rate such as prime plus a spread. Across the market this has commonly landed in the high single digits to the mid teens, and it moves with the base rate over the life of the facility. This is the part founders compare, and it is the smallest part of the story.
The lender takes the right to buy equity at the price of your last round. Coverage is quoted as a percentage of the facility — 10% warrant coverage on a $2M facility means $200K of stock at the last round price. This is real dilution, and it is worth more to the lender the better you do.
A balloon or end-of-term fee, commonly quoted as a few percent of the principal, due when the facility matures. It is easy to miss in a term sheet because it does not appear in the monthly payment.
Commitment or facility fees, legal costs, and a limited window to draw the money. Undrawn capital can still cost you, and an unused facility can expire.
A UCC-1 lien on company assets, reporting obligations, sometimes minimum cash or revenue covenants, and a material-adverse-change clause. Breaching a covenant can accelerate the whole loan — usually at the exact moment you can least afford it.
Typically an interest-only period followed by principal-plus-interest over the remaining term. The interest-only window is what makes the early months feel cheap; the amortising months are what you have to survive.
An illustration, not a quote. Terms are bespoke to each deal and each lender, so treat these as plausible mid-market assumptions rather than a market average: a $2,000,000 facility, 12% interest, a 36-month term with the first 12 months interest-only, a 3% final payment, and 10% warrant coverage.
Interest, 12 months interest-only: about $240,000
Interest, 24 months amortising down to zero: about $245,000
Final payment at maturity, 3% of principal: $60,000
Cash cost before warrants: about $545,000
Warrants, 10% coverage: $200,000 of stock at your last round’s price
So a facility that was pitched at “12%” costs roughly $545,000 in cash on $2M — and hands over $200,000 of equity at a price that only looks cheap in hindsight. If the company triples before the warrants are exercised, that $200,000 slice is worth far more than the interest ever was. That is the part worth modelling before you sign, and you can put a number on it with the free dilution calculator and the runway calculator.
These are the two structures founders most often weigh against each other, and they are underwritten on opposite things. Venture debt prices your investors. Revenue based financing prices your revenue. That single difference drives every row below.
Factor | Venture Debt | Revenue Based Financing |
|---|---|---|
Who qualifies | VC-backed companies with a priced round and a named lead investor | Any B2B SaaS company with recurring revenue — Founderpath starts at $10K MRR, no investors required |
Equity attached | Warrants, quoted as a percentage of the facility — real dilution on top of interest | None. No warrants, no equity, no board seats |
What it is priced on | Your investors, your last round, and your runway | Your recurring revenue — MRR, growth, churn, and gross margin |
Cost structure | Floating interest + warrants + a final payment + fees | A fixed discount rate from 7%, or interest from 15% on a term loan — disclosed in full before you accept |
Covenants | Reporting covenants, a lien on company assets, sometimes minimum cash or revenue tests | No financial covenants and no personal guarantee |
Speed to money | Weeks — diligence, sponsor calls, and legal documentation | An offer in about 24 hours after you connect billing and banking data |
If you miss a month | A covenant breach can accelerate the facility and put the lien in play | Fixed monthly payments with no covenant to trip; you work it out with the lender |
What it is for | Extending runway between equity rounds without repricing the company | Funding growth — hiring, marketing, inventory — out of revenue you already have |
Neither is strictly better. If you are VC-backed, mid-round, and need to reach a milestone before your next raise, venture debt is usually the cheaper way to buy that time. If you are bootstrapped and growing on your own revenue, revenue based financing is the one you can actually get — and it does not cost you equity. You can compare the whole non-dilutive market in the revenue based financing companies roundup.
Venture debt is often sold as the non-dilutive alternative to another equity round. It is less dilutive, not non-dilutive. A priced round typically sells 15–30% of the company; warrant coverage on a facility sells a far smaller slice. But warrants are still equity, and the honest way to compare the two is to convert the warrants into a percentage of the cap table and put it next to the round you would otherwise raise.
The second difference is control. Venture capital brings board seats, information rights, and an expectation about the shape of your outcome. Venture debt brings covenants and a lien instead — fewer opinions about strategy, more constraints on the balance sheet. If you are weighing an equity round at all, the venture capital guide walks through what you give up, and non-dilutive funding covers what is available if you would rather not.
Three kinds of lender, with genuinely different behaviour:
Banks with venture practices. The cheapest headline rates, the tightest covenants, and usually a requirement to move your operating accounts across. Diligence is the slowest of the three.
Specialist venture-debt funds. More expensive than banks and more flexible on structure. They price for the equity upside, so warrant coverage matters more here than the coupon does.
Fintech and revenue-based lenders. Faster and lighter on process, and the group most likely to lend without a VC round — but at that point you are usually looking at revenue-underwritten capital rather than venture debt proper.
Whichever you talk to, ask for the same four numbers before you compare anything: the interest rate, the warrant coverage, the final payment, and every covenant in the document. Two facilities with the same coupon can differ enormously once those are on the table. For a side-by-side against a specific bank venture-debt programme, see Founderpath vs SVB.
Founderpath does not offer venture debt, and does not require you to have raised one. It funds bootstrapped SaaS companies against their recurring revenue: qualify from $10K MRR, get an offer in about 24 hours after connecting your billing and banking data, and keep 100% of your equity — no warrants, no board seats, no personal guarantee, no financial covenants, and no closing costs.
Two structures: Revenue Financing at a 7% discount rate over 12–36 months for companies from $10K MRR, and Term Loans from 15% interest over up to 48 months for companies above $3M ARR, with interest-only payments for up to the first 24. Both use fixed monthly payments and disclose the full cost before you accept.
Answer 3 quick questions to get a personalized recommendation.
Question 1 of 3
Founderpath has deployed $271M to 743 bootstrapped SaaS founders. Connect your data, get a fixed funding offer, keep all your equity.
What Founderpath financing includes
No equity — keep 100% of your company
No board seats, no warrants, no covenants
Funding offer in 24 hours after connecting data
Fixed monthly payments — no revenue percentage
No closing costs or origination fees
Minimum $10K MRR — worldwide eligible